40.34 M
About Achilles Therapeutics PLC Sponsored ADR
Sector
Industry
CEO
Iraj Ali
Website
Headquarters
Altrincham
Founded
2020
ISIN
US00449L1026
FIGI
BBG0100R5MN9
Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.